How much funding has HELIXBIND, INC. raised?

HELIXBIND, INC. has raised $4.7M in total funding, most recently a Grant round.

Who are HELIXBIND, INC.'s investors?

HELIXBIND, INC.'s investors include HHS, CARB-X, National Institutes of Health, Angel investors.

When was HELIXBIND, INC. founded?

HELIXBIND, INC. was founded in 2015.

Where is HELIXBIND, INC. headquartered?

HELIXBIND, INC. is headquartered in BOXBOROUGH, Massachusetts, United States.

What industry is HELIXBIND, INC. in?

HELIXBIND, INC. operates in Biotech, Diagnostics, Healthcare, Medical Devices.

How many employees does HELIXBIND, INC. have?

HELIXBIND, INC. has 11-50 employees.

HELIXBIND, INC.

HELIXBIND | Identification of Bloodstream Infections | Boxborough, MA

BOXBOROUGH, United States · Founded 2015 · $4.7M raised

Headquarters: BOXBOROUGH, Massachusetts
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: helixbind.com
Total Funding: $4.7M
Last Round: $3.0M GrantJan 2022
Rounds: 3

About

HelixBind is developing an innovative diagnostic platform to revolutionize care for bloodstream infections and sepsis. Its proprietary technology delivers faster and more accurate microbiology results within four hours compared to the two-to-three days required by traditional blood culture tests, enabling clinicians to initiate precise antimicrobial treatment sooner. The platform is designed to reduce antimicrobial resistance and improve patient outcomes.

Summary

HELIXBIND, INC. is a Biotech company based in BOXBOROUGH, United States, founded in 2015. It has raised $4.7M in total across 3 rounds, most recently a $3.0M Grant round in Jan 2022. Investors include HHS, CARB-X and National Institutes of Health.